Loading…

Determination of hydrazine in a meningococcal C conjugate vaccine intermediary product

Abstract In Brazil, polysaccharide–protein conjugate vaccine against Neisseria meningitidis group C (MenCPS-TT) using hydrazine-activated-tetanus toxoid (TT) as a carrier protein has been developed. Because of the toxicity of hydrazine in humans, it is necessary to monitor this substance's proc...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2010-08, Vol.28 (34), p.5648-5651
Main Authors: Bastos, Renata Chagas, de Carvalho, Juliana Machado, da Silveira, Ivna Alana Freitas Brasileiro, do Couto Jacob, Silvana, Leandro, Katia Christina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract In Brazil, polysaccharide–protein conjugate vaccine against Neisseria meningitidis group C (MenCPS-TT) using hydrazine-activated-tetanus toxoid (TT) as a carrier protein has been developed. Because of the toxicity of hydrazine in humans, it is necessary to monitor this substance's process control step during the vaccine production. The electroanalytical methodology was developed and validated for the determination of hydrazine during the process control of MenCPS-TT vaccine production by differential pulse polarography. The reduction potential was −0.95 V in acetone and sulphuric acid solution. The method presented linear range between 30 and 150 μg L−1 and recovery of 93.5 ± 0.8%.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2010.05.079